Passive monitored daily motor behavior significantly relates to quality of life in early Parkinson’s disease
Objective: To investigate whether passively acquired measures of gait and hand gestures are associated with health-related quality of life (HrQoL; PDQ-39) and health-state (EQ-5D-5L) in…A Systematic Review of the Psychometric Properties of Psychosis Rating Scales in Neurodegenerative Conditions
Objective: To provide an overview of psychosis rating scales validated in specific neurodegenerative disease populations and compare psychometric characteristics of the validated psychosis scales. Background:…The Progressive Supranuclear Palsy Clinical Deficits Scale
Objective: To develop a scale to monitor clinical deficits in patients with Progressive Supranuclear Palsy across its broad phenotypes. Background: There is currently no undisputed,…Toward the digitization of the International Parkinson and Movement Disorder Society rating scales
Objective: Create recommendations for the electronic use of rating scales (e-scaled) owned or managed by the International Parkinson and Movement Disorder Society (MDS). Background: Medicine…Clinical and self-reported falls prediction tools in people with Parkinson’s disease
Objective: To externally validate the 3-step clinical prediction tool for identifying people with Parkinson’s disease (PD) at risk of falls; to validate this tool using…Feasibility of video-based motion analysis to rate the severity of tremor and bradykinesia in Parkinson’s disease
Objective: To evaluate the feasibility of video-based motion analysis for rating resting tremor and finger tapping in Parkinson’s disease. Background: Unified Parkinson’s Disease Rating Scale…Demonstrating the clinical value of MANAGE-PD tool in assessing symptom control of Parkinson’s disease patients: Evidence from G7 countries
Objective: Evaluate the clinical value of using MANAGE-PD tool for assessing PD symptom control in real-world setting. Background: MANAGE-PD is a validated [1], web-based tool…Agreement Between Neurologists on UPDRS Scoring and Symptom Laterality
Objective: Assess inter-rater reliability and agreement on symptom laterality when the UPDRS is performed by two raters. Background: The United Parkinson’s Disease Rating Scale (UPDRS)…Does “5-2-1” identify patients with suspected Advanced Parkinson’s Disease? Evidence of clinical accuracy from G7 countries
Objective: Evaluate the psychometric properties of (i) the “5-2-1” criteria and (ii) consensus-driven clinical indicators of suspected advanced Parkinson’s disease (APD). Background: Recent consensus panel…Endorsement of self-reported non-motor symptoms is associated with higher self-rated motor experiences of daily living in MDS-UPDRS part 2 in Parkinson’s disease
Objective: To quantify the extent to which self-perceived motor limitations (MDS-UPDRS part 2) relate to self-reported levels of non-motor symptom severity. Background: The MDS-UPDRS part…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 35
- Next Page »